Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday that it has increased its quarterly dividend for the first quarter of 2023.
The company has reported an increase in quarterly dividend of 15% to USD1.13 per share on the outstanding common stock for the first quarter of 2023.
The dividend will be paid to shareholders of record at 15 February 2023 on 10 March 2023.
Halozyme Therapeutics reports Q1 2023 financial results
Puma Biotechnology Posts 1Q23 Results
Pfizer declares results for first-quarter 2023